Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/SLCTR/2021/005
SLCTR/2021/005Not yet recruitingPhase 2

Assessment of the efficacy of the indigenous polyherbal drug Desandun Kalka” against SARS-CoV- 2 infection

Department of Ayurveda0 sitesStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •* Age > 18 years
  • •Both male and female
  • •* PCR positive for SARS-CoV- 2
  • •* The patient clinically assessed and categorized according to the tool published by Min. of Health, Sri Lanka, Provisional Guidelines for Clinical Management of COVID-19, (March 2020)” as patients with mild symptoms of SARS COVID-19 infection and defined as below:
  • •- Respiratory Rate (RR/min) 12 – 20
  • •- Heart Rate (HR/min) < 100
  • •- O2 Saturation – on room air (% by Pulse Oxymeter) > 94

Exclusion Criteria

  • •* Pregnant and breast feeding mothers
  • •* Those with severe and moderate illness (COVID 19)
  • •* Chronic Liver Cell Disease (CLCD),
  • •* Chronic Kidney Disease (CKD)
  • •* Those who are unable to take the drug orally

Investigators

Sponsor
Department of Ayurveda

Similar Trials

Not yet recruiting
Phase 2
To study the efficacy of an Indigenous Herbal Combination as an externalApplication in Skin itching, scaling, hyperpigmentation, discoloration, cracks & dryness
CTRI/2023/09/057534Supreem Pharmaceuticals Private Limited Mysuru
Not yet recruiting
Phase 1
A pilot study to assess the safety and efficacy of developed nano-surface dentalimplants.
CTRI/2023/07/054793Council of Scientific and Industrial Research
Completed
Phase 2
A Clinical Study on a Polyherbal Unani Formulation in the treatment of Chronic Gout (Hyperuricemia).
CTRI/2022/01/039544Central Council for Research in Unani Medicine New Delhi60
Recruiting
Phase 1
se of indeginous granules in Raktapradara with special reference to dysfunctional uterine bleeding
CTRI/2020/01/022795Darshana Yelne
Completed
Phase 4
A clinical trial to study effects of polyherbal formulation NSF3 in comparision with Zolpidem in patients with insomnia
CTRI/2011/12/002197Institute of PostGraduate Medical Education and Research92
Assessment of efficacy of the Indigenous... | Clinical Trial